A New Generation of Gene Therapies as the Future of Wet AMD Treatment

A New Generation of Gene Therapies as the Future of Wet AMD Treatment

Age-related macular degeneration (AMD) is an eye disease and the most common cause of vision loss in the Western World. In its advanced stage, AMD occurs in two clinically distinguished forms, dry and wet, but only wet AMD is treatable. However, the treatment based on repeated injections with vascul...

Full description

Bibliographic Details
Main Authors: Janusz Blasiak, Elzbieta Pawlowska, Justyna Ciupińska, Marcin Derwich, Joanna Szczepanska, Kai Kaarniranta
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
age-related macular degeneration
AMD
vascular endothelial growth factor
<i>VEGF</i>
anti-VEGF therapy
gene therapy
Online Access:https://www.mdpi.com/1422-0067/25/4/2386

Similar Items

Similar Items